Skip to main content
FinSpry Logo
FinSpry
TNGX logo
TNGX
(NASDAQ)
Tango Therapeutics, Inc.
$28.39-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Tango Therapeutics (TNGX) Stock Price & Financial Analysis

Tango Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$27.65 - $28.95
52-Week High$34.39
52-Week Low$4.60
Open$28.53
Volume6.31M
Average Volume (3M)4.65M
Market Cap4.02B
Shares Outstanding143.58M
Price to Sales (P/S)70.46
Price to Book (P/B)10.26
EV/EBITDA-35.67
Revenue (TTM)56.99M
Net Income (TTM)-107.23M
Free Cash Flow (TTM)-142.54M
EPS (TTM)$-0.88
Profit Margin-188.15%
Operating Margin-206.22%
Return on Equity (ROE)-27.39%
Debt to Equity0.08
50-Day MA$24.37
200-Day MA$14.34
52-Week Change482.71%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Tango Therapeutics

What is the current stock price for TNGX?

As of the latest trading session, TNGX stock trades at $28.50. The 52-week range is $4.60–$34.39, with a day range of $27.65–$28.95.

What is the P/E ratio for TNGX?

The P/E ratio (Price-to-Earnings) for TNGX is shown in the Key Statistics section. This valuation metric helps compare Tango Therapeutics, Inc. to industry peers.

Does TNGX pay dividends?

Tango Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for TNGX?

Based on 12 analysts, the consensus for TNGX is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of TNGX?

Tango Therapeutics's market capitalization is $4.09B, classifying it as a mid-cap company. Tango Therapeutics operates in the Healthcare sector within the Biotechnology industry.